logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
HIS Lite™ OG488-Tris NTA-Ni Complex
Fluorescent tris-NTA compounds provide an efficient method for site-specific and stable noncovalent fluorescence labeling of polyhistidine-tagged proteins. In contrast to the transient binding of conventional mono-NTA, the multivalent interaction of tris-NTA conjugated fluorophores form a much more stable complex with polyhistidine-tagged proteins. The high selectivity of tris-NTA compounds toward cumulated histidines enable the selective labeling of proteins in cell lysates and on the surface of live cells. Fluorescent tris-NTA conjugates can be applied for the analysis of a ternary protein complex in solution and on surfaces. The transition metal ions (e.g., Ni ion)-mediated complexation of polyhistidine-labeled proteins with fluorescent tris-NTA conjugates provides a sensitive reporter for detecting and monitoring protein-protein interactions in real time. This OG488-tris-NTA compound has been reported to be an sensitive fluorescent probe for detecting polyhistidine-labeled proteins in cells, solution and solid surfaces.
Chemical structure for HIS Lite™ OG488-Tris NTA-Ni Complex.
Chemical structure for HIS Lite™ OG488-Tris NTA-Ni Complex.
CatalogSize
Price
Quantity
12615100 ug
Price
 
Physical properties

Molecular weight1838.08
SolventWater
Spectral properties

Correction factor (260 nm)0.31
Correction factor (280 nm)0.12
Extinction coefficient (cm -1 M -1)
76000
Excitation (nm)498
Emission (nm)526
Storage, safety and handling

Intended useResearch Use Only (RUO)
StorageFreeze (< -15 °C); Minimize light exposure
Instrument settings

Gel Imager
ExcitationBlue laser
EmissionLong path green filter (SYBR filter)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 8, 2025